Grant Proposal Example Non Profit

INSTITUTIONAL GRANT AGREEMENT & PROGRAMMATIC AWARDEE COMPLIANCE PACT

Document ID: GA-202X-8841-NP
Effective Date: [Effective Date]
Version: 4.2 (Institutional Enterprise Edition)
Governing Jurisdiction: State of [State of Jurisdiction], United States

---

1. STATUTORY & LEGAL COMPLIANCE NOTICE

CRITICAL LEGAL NOTICE: This Grant Agreement is a legally binding contract establishing institutional funding, programmatic expectations, and fiduciary compliance standards between the Grantor and the Grantee. The enforceability of these terms is subject to the statutory frameworks governing charitable trusts, corporate giving, and federal/state tax exemptions (including, where applicable, the Internal Revenue Code of 1986, as amended). Legal counsel for both parties must review the structural alignment of the designated program with applicable local, state, and federal statutes prior to execution.

---

2. PARTIES & RECITALS

This Grant Agreement (the "Agreement") is entered into and made effective as of [Effective Date] (the "Effective Date"), by and between:

GRANTOR:
[Company Full Legal Name], a [State of Incorporation/Organization] [corporation/foundation/non-profit entity], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Grantor"), and

GRANTEE:
[Client Full Legal Name], a duly organized [501(c)(3) tax-exempt non-profit organization / legal entity], having its principal place of business located at [Principal Address] (hereinafter referred to as the "Grantee").

RECITALS

WHEREAS, the Grantor is a philanthropic entity dedicated to supporting high-impact initiatives, community development, and structural advancements within the scope of its institutional charter;
WHEREAS, the Grantee has submitted a formal grant proposal (attached hereto as Exhibit A and incorporated by this reference) seeking financial assistance for the execution of the specific programmatic initiative known as [Name of Program/Project] (the "Project");
WHEREAS, the Grantor has evaluated the Grantee’s proposal and agreed to award grant funds to the Grantee, subject to the strict terms, conditions, milestones, and fiduciary reporting standards set forth herein;

NOW, THEREFORE, in consideration of the mutual covenants, promises, and undertakings contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, the Parties agree as follows:

---

3. EXHAUSTIVE OPERATIVE CLAUSES & LEGAL TERMS

SECTION 1: SCOPE OF SERVICES & PROGRAMMATIC ENGAGEMENT

1.1 Grant Purpose. The Grantee shall use the Grant Funds (as defined herein) exclusively for the execution, administration, and completion of the Project as detailed in the approved Grant Proposal (Exhibit A). No portion of the Grant Funds may be diverted to any secondary purpose, operational overhead outside the approved budget, or lobbying activities inconsistent with the Grantee’s tax-exempt status without the prior express written authorization of the Grantor.
1.2 Milestone Execution. The Grantee shall execute the Project in accordance with the timeline, deliverables, and performance metrics set forth in Exhibit B (Milestone Schedule). The Grantee is obligated to notify the Grantor immediately in writing of any material operational, financial, or legal roadblocks that threaten the timely completion of any scheduled milestone.
1.3 Operational Autonomy. While the Grantee retains operational control over the daily execution of the Project, the Grantor reserves the right to review, audit, and evaluate programmatic progress to ensure strict compliance with institutional standards and the intended philanthropic impact.

SECTION 2: COMPENSATION & PAYMENT TERMS

2.1 Grant Amount. Subject to the terms and conditions of this Agreement, the Grantor agrees to disburse a total, fixed grant amount of [Amount in USD] USD (the "Grant Funds") to the Grantee.
2.2 Tranche-Based Disbursement. The Grant Funds shall be distributed in accordance with the following milestone-based disbursement schedule:

• Initial Tranche: [Amount in USD] USD, payable within thirty (30) business days following the full execution of this Agreement and the receipt of a compliant initial invoice.
• Secondary Tranche: [Amount in USD] USD, payable upon the successful completion and Grantor verification of Milestone 1, as set forth in Exhibit B, and the submission of a mid-term programmatic report.
• Final Tranche: [Amount in USD] USD, payable upon the final completion of the Project and the acceptance by the Grantor of the Comprehensive Final Financial and Programmatic Report.
  2.3 Invoicing Protocols. All requests for disbursement must be submitted via formal, itemized invoices directed to the Grantor’s designated Accounts Payable and Grant Operations department at [Grantor Invoicing Email Address]. Invoices must reference the Document ID (GA-202X-8841-NP) and include verification of prior fund utilization.
  2.4 Late Interest & Administrative Fees. Uncontested disbursements delayed past thirty (30) calendar days from the date of approved milestone verification shall accrue interest at the lesser of one and one-half percent (1.5%) per month or the maximum rate permitted by applicable law.
  2.5 Clawback & Repayment. The Grantee shall immediately refund and return to the Grantor any Grant Funds that are unexpended, uncommitted, or misallocated in violation of this Agreement upon the expiration or termination of this Agreement, or upon demand following an uncured material breach.

SECTION 3: TERM & TERMINATION

3.1 Term. This Agreement shall commence on the Effective Date and shall continue in full force and effect until [Project End Date] (the "Term"), unless terminated earlier in accordance with the provisions of this Section 3.
3.2 Termination for Convenience. The Grantor reserves the right to terminate this Agreement, in whole or in part, at any time and for any reason, by providing thirty (30) calendar days' prior written notice to the Grantee. Upon receipt of such notice, the Grantee shall immediately halt all non-essential Project expenditures, preserve all programmatic documentation, and return any unencumbered Grant Funds.
3.3 Termination for Cause (Breach). Either Party may terminate this Agreement immediately upon written notice if the other Party materially breaches any representation, warranty, or covenant contained herein.
3.4 Cure Period. Except for breaches involving financial malfeasance, confidentiality, or intellectual property—which shall be subject to immediate termination without cure—the non-breaching Party shall provide the breaching Party with written notice detailing the alleged breach and a thirty (30) calendar day cure period. If the breaching Party fails to remedy the breach to the reasonable satisfaction of the non-breaching Party within the cure period, this Agreement shall terminate automatically upon the expiration of the thirtieth day.
3.5 Post-Termination Obligations. Upon termination, the Grantee shall deliver to the Grantor a final accounting of all expenditures, a summary of programmatic outputs achieved to date, and all physical or digital assets purchased or generated using the Grant Funds, as directed by the Grantor.

SECTION 4: INTELLECTUAL PROPERTY OWNERSHIP & WORK MADE FOR HIRE

4.1 Pre-Existing Intellectual Property. Each Party shall retain sole, exclusive ownership of all patents, copyrights, trademarks, trade secrets, and proprietary methodologies owned or controlled by such Party prior to the Effective Date ("Pre-Existing IP"). Nothing in this Agreement shall be construed to transfer rights in Pre-Existing IP.
4.2 Project Intellectual Property. All deliverables, research data, reports, software code, educational materials, and creative works specifically developed, authored, or reduced to practice by the Grantee in the performance of the Project (collectively, "Project IP") shall be treated as a "work made for hire" under the copyright laws of the United States. To the extent that any Project IP does not qualify as a work made for hire, the Grantee hereby irrevocably assigns, transfers, and conveys to the Grantor all right, title, and interest in and to such Project IP worldwide, including all intellectual property rights therein.
4.3 Grantee License to Use. The Grantor hereby grants to the Grantee a non-exclusive, royalty-free, revocable, worldwide license to use the Project IP solely for the internal, non-commercial execution of the Grantee’s non-profit mission during the Term of this Agreement.

SECTION 5: MUTUAL CONFIDENTIALITY & NON-DISCLOSURE

5.1 Definition of Confidential Information. "Confidential Information" shall include all non-public, proprietary, or commercially sensitive information disclosed by one Party (the "Disclosing Party") to the other Party (the "Receiving Party") under this Agreement, whether orally, visually, or in writing, that is designated as confidential or that reasonably should be understood to be confidential given the nature of the information and the circumstances of disclosure.
5.2 Obligations of Confidentiality. The Receiving Party shall hold all Confidential Information in strict confidence, shall use the same solely for the purpose of performing its obligations under this Agreement, and shall not disclose such Confidential Information to any third party, except to its directors, officers, employees, legal counsel, and financial advisors who have a strict need to know and are bound by legal or professional confidentiality obligations at least as restrictive as those contained herein.
5.3 Exclusions. Confidential Information shall not include information that: (a) is or becomes generally available to the public other than as a result of a breach of this Agreement by the Receiving Party; (b) was already known to the Receiving Party prior to disclosure; (c) is independently developed by the Receiving Party without reference to or use of the Disclosing Party’s Confidential Information; or (d) is required to be disclosed by law, regulation, or court order, provided the Receiving Party gives prompt written notice to the Disclosing Party.

SECTION 6: REPRESENTATIONS & WARRANTIES

6.1 Grantee Representations. The Grantee represents and warrants that:

• (a) It is a duly organized, validly existing, and tax-exempt entity in good standing under the laws of its jurisdiction of organization and possesses all requisite power and authority to enter into and perform this Agreement.
• (b) The execution, delivery, and performance of this Agreement have been duly authorized by all necessary corporate and governance actions of the Grantee.
• (c) The execution of this Agreement and the fulfillment of the Project do not and will not violate any provision of the Grantee’s organizational documents, bylaws, or any contract, mortgage, or court order to which it is a party.
• (d) The Grantee maintains valid and active 501(c)(3) status with the Internal Revenue Service (or equivalent international status) and shall immediately notify the Grantor of any revocation, suspension, or threatened modification of such tax-exempt status.
  6.2 Grantor Representations. The Grantor represents and warrants that it possesses the full legal power, financial capacity, and corporate authority to disburse the Grant Funds and enter into this binding institutional agreement.

SECTION 7: LIMITATION OF LIABILITY & INDEMNIFICATION

7.1 Limitation of Liability. EXCEPT FOR LIABILITY ARISING FROM FRAUD, WILLFUL MISCONDUCT, OR BREACHES OF SECTION 5 (CONFIDENTIAL INFORMATION), NEITHER PARTY SHALL BE LIABLE TO THE OTHER FOR ANY INDIRECT, INCIDENTAL, CONSEQUENTIAL, SPECIAL, PUNITIVE, OR EXEMPLARY DAMAGES, INCLUDING LOST PROFITS OR LOSS OF REVENUE, ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THE GRANTOR’S MAXIMUM AGGREGATE LIABILITY UNDER THIS AGREEMENT SHALL UNDER NO CIRCUMSTANCES EXCEED THE TOTAL GRANT AMOUNT ACTUALLY DISBURSED TO THE GRANTEE.
7.2 Grantee Indemnification. The Grantee shall defend, indemnify, and hold harmless the Grantor, its directors, officers, employees, agents, and affiliates from and against any and all claims, liabilities, losses, damages, demands, judgments, settlements, and expenses (including reasonable attorneys' fees and legal costs) arising out of or resulting from: (a) any negligent act, omission, or willful misconduct of the Grantee, its employees, or subcontractors in connection with the Project; (b) any breach of the Grantee’s representations, warranties, or covenants under this Agreement; or (c) any violation of applicable laws, regulations, or third-party rights by the Grantee.

SECTION 8: DISPUTE RESOLUTION & ARBITRATION

8.1 Good Faith Negotiations. In the event of any dispute, controversy, or claim arising out of or relating to this Agreement, the Parties shall first attempt in good faith to resolve the matter through direct negotiations between designated senior executives of each Party within fifteen (15) business days of receiving written notice of the dispute.
8.2 Binding Arbitration. If the dispute cannot be resolved via negotiations within the specified timeframe, the matter shall be submitted to final and binding arbitration administered by the American Arbitration Association (AAA) in accordance with its Commercial Arbitration Rules. The place of arbitration shall be [City, State]. The arbitration shall be conducted by a single neutral arbitrator appointed in accordance with said rules. The award rendered by the arbitrator shall be final, and judgment upon the award may be entered in any court having jurisdiction thereof.

SECTION 9: GOVERNING LAW & JURISDICTION

9.1 Governing Law. This Agreement, and all claims or causes of action (whether in contract, tort, or statute) that may be based upon, arise out of, or relate to this Agreement, shall be governed by, enforced under, and construed in accordance with the internal laws of the State of [State of Jurisdiction], without regard to its conflict of laws principles.
9.2 Jurisdiction. Subject to Section 8, each Party irrevocably and unconditionally submits to the exclusive jurisdiction of the state and federal courts located within [County Name] County, [State of Jurisdiction], for any legal action, suit, or proceeding arising out of or relating to this Agreement.

SECTION 10: MISCELLANEOUS

10.1 Severability. If any provision of this Agreement is held to be invalid, illegal, or unenforceable by a court of competent jurisdiction, such provision shall be modified to the minimum extent necessary to make it valid and enforceable, and the remaining provisions of this Agreement shall remain in full force and effect.
10.2 Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Delivery of an executed counterpart of a signature page by electronic mail (PDF) or digital signature platform shall be effective as manual delivery of a physically executed counterpart.
10.3 Entire Agreement. This Agreement, including the attached Exhibits A and B, constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes all prior and contemporaneous discussions, negotiations, proposals, commitments, and understandings, whether written or oral. No modification, amendment, or waiver of any provision of this Agreement shall be effective unless set forth in a written instrument signed by authorized representatives of both Parties.

---

4. EXECUTION & FORMAL SIGNATURE BLOCKS

IN WITNESS WHEREOF, the Parties hereto have caused this institutional Grant Agreement to be duly executed by their respective authorized officers as of the Effective Date written above.

FOR [PARTY A / COMPANY NAME]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Company Legal Name]
Date: [Date]

FOR [PARTY B / CLIENT / COUNTERPARTY]:
Signature: _____________________________________
Printed Name: [Authorized Signatory Name]
Title: [Title / Role]
Company: [Client Full Legal Name]
Date: [Date]

---

5. STEP-BY-STEP EXECUTION & FILING GUIDE

1. Document Preparation & Variable Customization: Open this document template in Microsoft Word or Google Docs. Utilize the Find & Replace function to locate all bracketed fields (e.g., [Company Full Legal Name], [Amount in USD], [Effective Date]) and replace them with the exact verified legal particulars of the transaction. Ensure Exhibits A (Grant Proposal) and B (Milestone Schedule) are fully drafted and appended.
2. Legal & Compliance Review: Route the completed draft to internal legal counsel and the Chief Financial Officer (CFO) or Grant Operations department to confirm that the financial tranches, tax-exempt verification (IRS 501(c)(3) or equivalent), and scope parameters align with institutional risk tolerance.
3. Signatory Authority Verification: Confirm that the individuals executing the agreement on behalf of both the Grantor and the Grantee possess verified corporate, board, or administrative authority to bind their respective institutions.
4. Digital Execution: Export the finalized document as a secure PDF and upload it to an institutional-grade digital signature platform (such as DocuSign or Adobe Sign). Route the document for execution in the following order: (1) Grantee Signatory, followed by (2) Grantor Signatory.
5. Post-Execution Filing & Record Retention: Upon full execution, store the master countersigned PDF within the institutional Enterprise Contract Management System (CMS) or secure cloud repository under Document ID GA-202X-8841-NP. Establish calendar alerts for milestone review dates, mid-term reporting windows, and the final expiration date to ensure continuous compliance tracking.